American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Broadcom
AVGO
|
+$250M |
| 2 |
Workday
WDAY
|
+$183M |
| 3 |
Apple
AAPL
|
+$178M |
| 4 |
Eli Lilly
LLY
|
+$172M |
| 5 |
GE Vernova
GEV
|
+$159M |
Top Sells
| 1 |
Visa
V
|
+$494M |
| 2 |
Colgate-Palmolive
CL
|
+$234M |
| 3 |
NXP Semiconductors
NXPI
|
+$184M |
| 4 |
Duke Energy
DUK
|
+$176M |
| 5 |
Intuitive Surgical
ISRG
|
+$166M |
Sector Composition
| 1 | Technology | 26.52% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 11.51% |
| 4 | Healthcare | 11.16% |
| 5 | Industrials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2726
908 Devices
MASS
$202M
| $144K | ﹤0.01% |
41,435
+7,717
| +23% | +$26.8K |
|
2727
Evolv Technologies
EVLV
$1.51B
| $142K | ﹤0.01% |
+35,155
| New | +$142K |
|
2728
Travelzoo
TZOO
$105M
| $141K | ﹤0.01% |
11,661
+884
| +8% | +$10.7K |
|
2729
Savers
SVV
$1.94B
| $140K | ﹤0.01% |
+13,325
| New | +$140K |
|
2730
CCC Intelligent Solutions
CCCS
$6.37B
| $138K | ﹤0.01% |
+12,510
| New | +$138K |
|
2731
ON24
ONTF
$232M
| $137K | ﹤0.01% |
+22,386
| New | +$137K |
|
2732
Personalis
PSNL
$519M
| $136K | ﹤0.01% |
+25,310
| New | +$136K |
|
2733
Acumen Pharmaceuticals
ABOS
$80M
| $135K | ﹤0.01% |
54,543
+9,099
| +20% | +$22.6K |
|
2734
Opko Health
OPK
$1.11B
| $134K | ﹤0.01% |
89,728
| – | – |
|
2735
Ventyx Biosciences
VTYX
$164M
| $131K | ﹤0.01% |
59,915
+34,032
| +131% | +$74.2K |
|
2736
Ultralife
ULBI
$114M
| $128K | ﹤0.01% |
+14,130
| New | +$128K |
|
2737
Cardiff Oncology
CRDF
$136M
| $128K | ﹤0.01% |
47,815
+2,455
| +5% | +$6.56K |
|
2738
Lantronix
LTRX
$174M
| $126K | ﹤0.01% |
30,535
+4,216
| +16% | +$17.4K |
|
2739
OppFi
OPFI
$312M
| $122K | ﹤0.01% |
25,872
+4,703
| +22% | +$22.2K |
|
2740
Tilly's
TLYS
$57.3M
| $116K | ﹤0.01% |
22,831
+70
| +0.3% | +$357 |
|
2741
Groupon
GRPN
$923M
| $116K | ﹤0.01% |
+11,874
| New | +$116K |
|
|
RDNW
2742
RideNow Group, Inc. Class B Common Stock
RDNW
$156M
| $114K | ﹤0.01% |
23,862
+1,736
| +8% | +$8.32K |
|
2743
Sensus Healthcare
SRTS
$52.3M
| $114K | ﹤0.01% |
+19,646
| New | +$114K |
|
2744
Repare Therapeutics
RPTX
$75.6M
| $113K | ﹤0.01% |
32,802
+142
| +0.4% | +$488 |
|
2745
OptimizeRx
OPRX
$322M
| $113K | ﹤0.01% |
14,612
-24,772
| -63% | -$191K |
|
|
API
2746
Agora
API
$343M
| $111K | ﹤0.01% |
45,925
+820
| +2% | +$1.98K |
|
2747
Lumen
LUMN
$6.21B
| $110K | ﹤0.01% |
+15,437
| New | +$110K |
|
2748
Zentalis Pharmaceuticals
ZNTL
$107M
| $108K | ﹤0.01% |
29,475
+6,163
| +26% | +$22.7K |
|
|
ATYR
2749
aTyr Pharma
ATYR
$591M
| $108K | ﹤0.01% |
61,596
+1,109
| +2% | +$1.95K |
|
2750
Acrivon Therapeutics
ACRV
$47.8M
| $108K | ﹤0.01% |
+15,402
| New | +$108K |
|